Clinical Guidelines & Pathways
Osteoporosis Guideline
Guideline added to website on: 08/06/2020
Last modified on: 10/12/2020
CCG: Bedfordshire | Luton
Section: Clinical Guidelines & Pathways
Category: Care of the Elderly | Osteoporosis
Tags: bisphosphonate, denosumab, Osteoporosis
Please note this guideline is in the process of being updated to incorporate the MHRA advice regarding NOT stopping or delaying ongoing denosumab treatment WITHOUT a specialist review . (See below the red coloured 'view guideline PDF' box for a link to the full MHRA drug safety update.)
(The previous osteoporosis guidelines (April 2019) are attached for reference only purposes)